“A Review of the Genetic Variants Affecting Efficacy and Adverse Effects of Standard of Care Treatment in Patients With Chronic Myelogenous Leukemia”. 2022. Precision Medicine Communications 2 (1): 43-58. https://doi.org/10.55627/pmc.002.01.0045.